HJO  >> Vol. 4 No. 3 (September 2015)

    曲安奈德后Tenon囊下注射治疗Vogt-小柳-原田氏病黄斑部浆液性脱离
    Injection of Triamcinolone Acetonide (TA) under Tenon’s on the Macular Serous Retinal Detachment of Vogt-Koyanagi-Harada (VKH) Disease

  • 全文下载: PDF(638KB) HTML   XML   PP.47-51   DOI: 10.12677/HJO.2015.43009  
  • 下载量: 1,312  浏览量: 4,522  

作者:  

肖 静,高付林,郭惠玲:解放军306医院眼科,北京

关键词:
Vogt-小柳-原田氏病曲安奈德Tenon’s囊Vogt-Koyanagi-Harada Disease Triamcinolone Acetonide Tenon’s Capsure

摘要:

目的:观察曲安奈德球后Tenon囊下注射联合全身糖皮质激素治疗Vogt-小柳-原田氏病的临床疗效。方法:经眼底荧光血管造影和频域OCT确诊的Vogt-小柳-原田氏病18例34眼,病变急性期给予行大剂量糖皮质激素冲击治疗,激素减量期间结合曲安奈德后Tenon囊下注射,时间为每月1次,20 mg/0.5 ml次,共3次。所有患者在治疗前及治疗后检查裸眼视力、最佳矫正视力、眼前节检查、眼底彩照和频域光相干断层扫描,并使用SPSS17.0 对数据进行统计学分析。结果:治疗后所有患者视力均有不同程度提高。治疗前所有患者造影出现多数针尖状高荧光点和多湖状高荧光斑,治疗6个月,32眼荧光素眼底血管造影未见异常,其平均高度为378 ± 234 um。治疗后其平均高度为153 ± 67 um,比治疗前平均下降59.5%。两组比较差异有显著统计学意义(p < 0.01)。结论:曲安奈德后Tenon’s注射治疗Vogt-小柳-原田病,能够明显改善黄斑区的浆液性视网膜脱离并能减少疾病的复发。

Objectives: To observe the clinic effect of Vogt-Koyanagi- Harada (VKH) Disease by injecting triamcinolone acetonide (TA) under Tenon’s. Methods: 34 eyes of 18 consecutive patients diagnosed with acute Vogt-Koyanagi-Harada Disease by FFA and OCT. All the patients were given pmethylprednisolone combined with triamcinolone acetonide (TA) injection under Tenon’s, and the frequency is once a month, 20 mg/0.5ml every time, and it will be done totally three times. All the patients were performed no-corrected visual activity, best corrected visual activity, slit- lamp check, fundus photograph and spectral-domain optical coherence tomography (OCT) at the initial visit and 6 months after steroid treatment. All the data were analyzed by SPSS 17.0. Results: After the treatment, all the patients’ VA improved. At the initial, all eyes showed the most hyperfluorescence pinpoints and the leakage of fluorescence pooling. After treatment for 6 months, the FFA of 32 patients showed normal. The thickness of fovea was (378 ± 234) μm before treatment and (153 ± 67) μm after treatment, which decreased by 59.5% on average; there was significantly difference between the two groups (p < 0.01). Conclusion: For VHK disease, the treatment of pmethylprednisolone combined with TA injection under Tenon’s can improve the macular serous retinal detachment and reduce the relapse of the disease.

文章引用:
肖静, 高付林, 郭惠玲. 曲安奈德后Tenon囊下注射治疗Vogt-小柳-原田氏病黄斑部浆液性脱离[J]. 眼科学, 2015, 4(3): 47-51. http://dx.doi.org/10.12677/HJO.2015.43009

参考文献

[1] Read, R., Yu, F., Accorinti, M., Bodaghi, B., Chee, S.-P., Fardeau, C., et al. (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. American Journal of Ophthalmology, 142,119-124.
http://dx.doi.org/10.1016/j.ajo.2006.02.049
[2] 杨培增 (2004) 临床葡萄膜炎. 人民卫生出版社, 北京, 293.
[3] Rao, N.A., Sukavatchsrin, S. and Tsai, J.H. (2007) Vogt-Koyanagi-Harada disease diagnostic criteria. International Ophthalmology, 27, 195-199.
http://dx.doi.org/10.1007/s10792-006-9021-x
[4] Durrani, O.M., Meads, C.A. and Murray, P.I. (2004) Uveitis: A potentially blinding disease. Ophthalmologica, 218, 223-236.
http://dx.doi.org/10.1159/000078612
[5] Martidis, A., Duker, J.S., Greenbery, P.B., Rogers, A.H., Puliafito, C.A., Reichel, E. and Baumal, C. (2002) Intravitreal triamcinolone forefractory diabetic macular edema. Ophthalmology, 109, 920-927.
http://dx.doi.org/10.1016/S0161-6420(02)00975-2
[6] Andrade, R., Muccioli, C. and Farah, M. (2004) Intravi-treal triamcinolone acetonide injection in the treatment of Vogt- Koyanagi-Harada syndrome. Arquivos Brasileiros de Oftalmologia, 67, 401-406.
http://dx.doi.org/10.1590/S0004-27492004000300005
[7] Couch, S.M. and Bakri, S.J. (2009) Intravitreal triam-cinolone for intraocular inflammation and associated macular edema. Clinical Ophthalmology, 3, 41-47.
[8] Perente, I., Utice, C.A., Cakir, H., Kaya, V., Tutkun, I.T. and Yilmaz, O.F. (2009) Management of ocular complications of Vogt-Koyanagi-Harada syndrome. International Ophthalmology, 29, 33-37.
http://dx.doi.org/10.1007/s10792-007-9159-1
[9] 关红英, 李双农 (2009) 后Tenon囊下注射曲安奈德后玻璃体腔内药物质量浓度的测定. 眼科研究, 6, 507-510.